<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05425023687338</udiDi>
    <basicUdiDi>542502368BDDCROHNHE</basicUdiDi>
    <tradeName>ASCA Screen IgA+IgG Dot for BDI</tradeName>
    <deviceName></deviceName>
    <manufacturerName>D-tek s.a.</manufacturerName>
    <manufacturerSrn>BE-MF-000024530</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102100801</emdnCode>
    <emdnDescription>SACCHAROMYCES CEREVISIAE ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AD ASCASDBD</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-31T08:04:18.949Z</lastUpdated>
  </row>
  <row>
    <udiDi>86060313276226</udiDi>
    <basicUdiDi>B-86060313276226</basicUdiDi>
    <tradeName>Lysozyme</tradeName>
    <deviceName>Lysozyme</deviceName>
    <manufacturerName>NEOMEDICA DOO NIŠ</manufacturerName>
    <manufacturerSrn>RS-MF-000021305</manufacturerSrn>
    <authorisedRepresentativeName>Wellkang Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>XI-AR-000001836</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C1815LYS</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:15:19.491Z</lastUpdated>
  </row>
  <row>
    <udiDi>86060313276080</udiDi>
    <basicUdiDi>B-86060313276080</basicUdiDi>
    <tradeName>Zonulin</tradeName>
    <deviceName>Zonulin</deviceName>
    <manufacturerName>NEOMEDICA DOO NIŠ</manufacturerName>
    <manufacturerSrn>RS-MF-000021305</manufacturerSrn>
    <authorisedRepresentativeName>Wellkang Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>XI-AR-000001836</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C1826ZON</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:15:14.690Z</lastUpdated>
  </row>
  <row>
    <udiDi>86060313275922</udiDi>
    <basicUdiDi>B-86060313275922</basicUdiDi>
    <tradeName>β-Defensin</tradeName>
    <deviceName>β-Defensin</deviceName>
    <manufacturerName>NEOMEDICA DOO NIŠ</manufacturerName>
    <manufacturerSrn>RS-MF-000021305</manufacturerSrn>
    <authorisedRepresentativeName>Wellkang Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>XI-AR-000001836</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C1818DEF</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:15:13.886Z</lastUpdated>
  </row>
  <row>
    <udiDi>86060313275236</udiDi>
    <basicUdiDi>B-86060313275236</basicUdiDi>
    <tradeName>EDN</tradeName>
    <deviceName>EDN</deviceName>
    <manufacturerName>NEOMEDICA DOO NIŠ</manufacturerName>
    <manufacturerSrn>RS-MF-000021305</manufacturerSrn>
    <authorisedRepresentativeName>Wellkang Ltd</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>XI-AR-000001836</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C1819EDN</reference>
    <placedOnMarketCountry>Northern Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-12T07:15:00.275Z</lastUpdated>
  </row>
  <row>
    <udiDi>08435287148725</udiDi>
    <basicUdiDi>B-08435287148725</basicUdiDi>
    <tradeName>08435287148725</tradeName>
    <deviceName>ASCA-IgG/IgA (ASCA)</deviceName>
    <manufacturerName>BIOSYSTEMS S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000000231</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100801</emdnCode>
    <emdnDescription>SACCHAROMYCES CEREVISIAE ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>44872</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T20:51:28.428Z</lastUpdated>
  </row>
  <row>
    <udiDi>07090028592505</udiDi>
    <basicUdiDi>B-07090028592505</basicUdiDi>
    <tradeName>07090028592505</tradeName>
    <deviceName>Calprosmart Self-Tesr</deviceName>
    <manufacturerName>Calpro AS</manufacturerName>
    <manufacturerSrn>NO-MF-000036194</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Kendi Kendine Test</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CAL250</reference>
    <placedOnMarketCountry>Norway</placedOnMarketCountry>
    <lastUpdated>2026-07-06T23:57:24.206Z</lastUpdated>
  </row>
  <row>
    <udiDi>07090028592406</udiDi>
    <basicUdiDi>B-07090028592406</basicUdiDi>
    <tradeName>07090028592406</tradeName>
    <deviceName>Calprosmart Self-Test</deviceName>
    <manufacturerName>Calpro AS</manufacturerName>
    <manufacturerSrn>NO-MF-000036194</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Kendi Kendine Test</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CAL230</reference>
    <placedOnMarketCountry>Norway</placedOnMarketCountry>
    <lastUpdated>2026-07-06T23:57:23.393Z</lastUpdated>
  </row>
  <row>
    <udiDi>07090028592307</udiDi>
    <basicUdiDi>B-07090028592307</basicUdiDi>
    <tradeName>07090028592307</tradeName>
    <deviceName>Calprosmart Sel-Test</deviceName>
    <manufacturerName>Calpro AS</manufacturerName>
    <manufacturerSrn>NO-MF-000036194</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Kendi Kendine Test</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CAL230</reference>
    <placedOnMarketCountry>Norway</placedOnMarketCountry>
    <lastUpdated>2026-07-06T23:57:22.583Z</lastUpdated>
  </row>
  <row>
    <udiDi>06975070767785</udiDi>
    <basicUdiDi>B-06975070767785</basicUdiDi>
    <tradeName>Sharay Anti-Saccharomyces cerevisiae IgG (CLIA)</tradeName>
    <deviceName>Sharay Anti-Saccharomyces cerevisiae IgG (CLIA)</deviceName>
    <manufacturerName>C-Luminary Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000035089</manufacturerSrn>
    <authorisedRepresentativeName>Sungo Cert GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000010869</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100801</emdnCode>
    <emdnDescription>SACCHAROMYCES CEREVISIAE ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>18199002</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T18:46:27.075Z</lastUpdated>
  </row>
  <row>
    <udiDi>06975070767778</udiDi>
    <basicUdiDi>B-06975070767778</basicUdiDi>
    <tradeName>Sharay Anti-Saccharomyces cerevisiae IgA (CLIA)</tradeName>
    <deviceName>Sharay Anti-Saccharomyces cerevisiae IgA (CLIA)</deviceName>
    <manufacturerName>C-Luminary Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000035089</manufacturerSrn>
    <authorisedRepresentativeName>Sungo Cert GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000010869</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100801</emdnCode>
    <emdnDescription>SACCHAROMYCES CEREVISIAE ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>18163002</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T18:46:26.276Z</lastUpdated>
  </row>
  <row>
    <udiDi>06975070767747</udiDi>
    <basicUdiDi>B-06975070767747</basicUdiDi>
    <tradeName>Sharay Anti-Intestinal Goblet Cell IgG (CLIA)</tradeName>
    <deviceName>Sharay Anti-Intestinal Goblet Cell IgG (CLIA)</deviceName>
    <manufacturerName>C-Luminary Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000035089</manufacturerSrn>
    <authorisedRepresentativeName>Sungo Cert GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000010869</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>18161002</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T18:46:19.870Z</lastUpdated>
  </row>
  <row>
    <udiDi>06975070767730</udiDi>
    <basicUdiDi>B-06975070767730</basicUdiDi>
    <tradeName>Sharay Anti-Intestinal Goblet Cell IgA (CLIA)</tradeName>
    <deviceName>Sharay Anti-Intestinal Goblet Cell IgA (CLIA)</deviceName>
    <manufacturerName>C-Luminary Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000035089</manufacturerSrn>
    <authorisedRepresentativeName>Sungo Cert GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000010869</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102100899</emdnCode>
    <emdnDescription>OTHERS INFLAMATORY BOWEL DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>18162002</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T18:46:19.073Z</lastUpdated>
  </row>
  <row>
    <udiDi>07333066015705</udiDi>
    <basicUdiDi>7333066BUDI0117M4</basicUdiDi>
    <tradeName>EliA ASCA IgG Well</tradeName>
    <deviceName>EliA ASCA IgG</deviceName>
    <manufacturerName>Phadia AB</manufacturerName>
    <manufacturerSrn>SE-MF-000014170</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102100801</emdnCode>
    <emdnDescription>SACCHAROMYCES CEREVISIAE ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>14-5635-01</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-03T01:17:23.403Z</lastUpdated>
  </row>
  <row>
    <udiDi>07333066015699</udiDi>
    <basicUdiDi>7333066BUDI0028M4</basicUdiDi>
    <tradeName>EliA ASCA IgA Well</tradeName>
    <deviceName>EliA ASCA IgA</deviceName>
    <manufacturerName>Phadia AB</manufacturerName>
    <manufacturerSrn>SE-MF-000014170</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102100801</emdnCode>
    <emdnDescription>SACCHAROMYCES CEREVISIAE ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>14-5633-01</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-03T01:17:22.596Z</lastUpdated>
  </row>
  <row>
    <udiDi>05425023688168</udiDi>
    <basicUdiDi>542502368BDDCROHNHE</basicUdiDi>
    <tradeName>DIASpot Neptune ASCA IgG + IgA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>D-tek s.a.</manufacturerName>
    <manufacturerSrn>BE-MF-000024530</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W0102100801</emdnCode>
    <emdnDescription>SACCHAROMYCES CEREVISIAE ANTIBODIES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>KAPDTASCCN</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-25T14:23:49.097Z</lastUpdated>
  </row>
</eudamedExport>